Renalys

Catalyst to access novel therapies for Asian patients with renal disease.

HQ location

Tokyo, Japan

Website

Launch date

2023

Enterprise value

$185—277m

Date	Investors	Amount	Round
Jul 2024*	Nippon Venture Capital SR One Japan Co-Invest Limited Partnership Catalys Pacific Japan Post Investment Sumitomo Mitsui Trust Bank	JPY6.0b	Series A
Total Funding		000k

Unlock the full power of analytics with a premium account

Track company size and historic growth

Track team composition and strength

Track website visits and app downloads